|
MechanismNF-κB inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date01 Jan 1972 |
Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
|
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with ASAC Pharmaceutical Internacional AIE
0 Patents (Medical) associated with ASAC Pharmaceutical Internacional AIE
100 Deals associated with ASAC Pharmaceutical Internacional AIE
100 Translational Medicine associated with ASAC Pharmaceutical Internacional AIE